MEDP
Overvalued by 0.4% based on the discounted cash flow analysis.
Market cap | $11.60 Billion |
---|---|
Enterprise Value | $11.35 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $8.88 |
Beta | 1.0 |
Outstanding Shares | 30,983,185 |
Avg 30 Day Volume | 184,502 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 41.04 |
---|---|
PEG | 292.7 |
Price to Sales | 6.27 |
Price to Book Ratio | 20.9 |
Enterprise Value to Revenue | 6.02 |
Enterprise Value to EBIT | 33.7 |
Enterprise Value to Net Income | 40 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data